[1]
BelliC., CeredaS., NovarinoA., MilellaM., PassardiA., Di LuccaG., MambriniA., FerrariL., DanovaM., BergamoF., FranceschiE., GiovannettiE., RovatiB., GallàV., BalzanoG., AriottiR., VillaE. and ReniM. 2012. Clinical and Translational Results of a Phase II Randomized Trial of Maintenance Sunitinib or Observation in Metastatic Pancreatic Adenocarcinoma. JOP. Journal of the Pancreas. 13, 5S (Sep. 2012), 551. DOI:https://doi.org/10.6092/1590-8577/951.